School of Biological Sciences, Nanyang Technological University, Singapore, Singapore.
The University of Hong Kong (HKU) School of Professional and Continuing Education, Hong Kong, Hong Kong SAR, China.
Front Immunol. 2023 Aug 31;14:1234307. doi: 10.3389/fimmu.2023.1234307. eCollection 2023.
The World Health Organization declared that COVID-19 is no longer a public health emergency of global concern on May 5, 2023. Post-COVID disorders are, however, becoming more common. Hence, there lies a growing need to develop safe and effective treatment measures to manage post-COVID disorders. Investigating the use of TCM medicinal foods in the long-term therapy of post-COVID illnesses may be beneficial given contemporary research's emphasis on the development of medicinal foods.
The use of medicinal foods for the long-term treatment of post-COVID disorders is highlighted in this review. Following a discussion of the history of the TCM "Medicine and Food Homology" theory, the pathophysiological effects of post-COVID disorders will be briefly reviewed. An analysis of TCM medicinal foods and their functions in treating post-COVID disorders will then be provided before offering some insight into potential directions for future research and application.
TCM medicinal foods can manage different aspects of post-COVID disorders. The use of medicinal foods in the long-term management of post-COVID illnesses may be a safe and efficient therapy choice because they are typically milder in nature than chronic drug use. These findings may also be applied in the long-term post-disease treatment of similar respiratory disorders.
世界卫生组织于 2023 年 5 月 5 日宣布，新冠疫情不再构成全球关注的公共卫生紧急事件。然而，新冠后疾病变得越来越普遍。因此，需要开发安全有效的治疗措施来管理新冠后疾病。鉴于当代研究强调开发药用食品，因此研究中药食同源品在新冠后疾病的长期治疗中的应用可能是有益的。
本综述强调了中药食同源品在新冠后疾病的长期治疗中的应用。在讨论了中医“药食同源”理论的历史之后，将简要回顾新冠后疾病的病理生理影响。然后，将对中药食同源品及其在治疗新冠后疾病中的作用进行分析，最后为未来的研究和应用提供一些方向。
中药食同源品可以治疗新冠后疾病的不同方面。中药食同源品在新冠后疾病的长期管理中可能是一种安全有效的治疗选择，因为它们通常比慢性药物使用的性质更温和。这些发现也可能适用于类似呼吸道疾病的长期疾病后治疗。
